Stroke in Sickle Cell Disease

Practical Management of Haemoglobinopathies

Volumn , Issue , 2007, Pages 134-144

  Kwiatkowski, Janet ^a   Ohene Frempong, Kwaku ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Heart strokes; Red blood cell transfusion; Sickle cell disease (SCD); Stem cell transplantation; Transient ischaemic attack (TIA)

Indexed keywords

EID: 26444549568     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470988398.ch15     Document Type: Chapter

References (52)

1. Pavlakis SG, Bello J, Prohovnik I et al. Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol 1988; 23: 125-30.
2. Merkel KH, Ginsberg PL, Parker JC Jr et al. Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation. Stroke 1978; 9: 45-52.
3. Oyesiku NM, Barrow DL, Eckman JR et al. Intracranial aneurysms in sickle-cell anemia: clinical features and pathogenesis [see comments]. J Neurosurg 1991; 75: 356-63.
4. Diggs LW, Brookoff D. Multiple cerebral aneurysms in patients with sickle cell disease [see comments]. South Med J 1993; 86: 377-9.
5. Seeler RA, Royal JE, Powe L et al. Moyamoya in children with sickle cell anemia and cerebrovascular occlusion. J Pediatr 1978; 93: 808-10.
6. Russell MO, Goldberg HI, Reis L et al. Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. J Pediatr 1976; 88: 382-7.
7. Miller ST, Macklin EA, Pegelow CH et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001; 139: 385-90.
8. Pegelow C, Reed G, Moser F et al. Natural history of silent infarct in children with sickle cell anemia. Blood 1999;94 (Suppl 1): 199a.
9. Armstrong FD, Thompson RJ Jr, Wang W et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics 1996; 97: 864-70.
10. Brown RT, Davis PC, Lambert R et al. Neurocognitive functioning and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol 2000; 25: 503-13.
11. Wang WC, Gallagher DM, Pegelow CH et al. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol 2000:22: 335-9.
12. Ohene-Frempong K, Weiner SJ, Sleeper LA et al. Cere-brovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288-94.
13. Adams R, McKie V, Nichols F et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992; 326: 605-10.
14. Kirkham FJ, Hewes DK, Prengler M et al. Nocturnal hypoxaemia and central-nervous-system events in sicklecell disease. Lancet 2001; 357: 1656-9.
15. Driscoll MC, Hurlet A, Styles L et al. Stroke risk in siblings with sickle cell anemia. Blood 2003; 101: 2401.
16. Hoppe C, Klitz W, Noble J et al. Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 2003; 101: 2865-9.
17. Houston PE, Rana S, Sekhsaria S et al. Homocysteine in sickle cell disease: relationship to stroke. Am J Med 1997; 103: 192-6.
18. Kwiatkowski JL, Hunter JV, Smith-Whitley K et al. Transcranial Doppler ultrasonography in siblings with sickle cell disease. Br J Haematol 2003; 121: 932-7.
19. Reith J, Jorgensen S, Pedersen PM et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996; 347: 422-5.
20. Tissue plaminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-7.
21. Powars D, Wilson B, Imbus C et al. The natural history of stroke in sickle cell disease. Am J Med 1978; 65: 461-71.
22. Balkaran B, Char G, Morris JS et al. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360-6.
23. Murphy JR, Wengard M, Brereton W. Rheological studies of HbSS blood: influence of hematocrit, hyperviscosity, separation of cells, deoxygenation, and mixture with normal cells. J Lab Clin Med 1976; 87: 475.
24. Sarnaik S, Soorya D, Kim J et al. Periodic transfusions for sickle cell anemia and CNS infarction. Am J of Dis Child 1979; 133: 1254-7.
25. Wilimas J, Goff JR, Anderson HR Jr et al. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 1980; 96: 205-8.
26. Pegelow CH, Adams RJ, McKie V et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995; 126: 896-9.
27. Scothorn DJ, Price C, Schwartz D et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002; 140: 348-54.
28. Buchanan GR, Bowman WP, Smith SJ. Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia. J Pediatr 1983; 103: 921-3.
29. Russell MO, Goldberg HI, Hodson A et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984; 63: 162-9.
30. Wang WC, Kovnar EH, Tonkin IL et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991; 118: 377-82.
31. Rana S, Houston PE, Surana N et al. Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke. J Pediatr 1997; 131: 757-60.
32. Cohen AR, Martin MB, Silber JH et al. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992; 79: 1657-61.
33. Miller ST, Jensen D, Rao SP. Less intensive long-term transfusion therapy for sickle cell anemia and cere-brovascular accident. J Pediatr 1992; 120: 54-7.
34. Kim HC, Dugan NP, Silber JH et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994; 83: 1136-42.
35. Vichinsky E. Consensus document for transfusion- related iron overload. Semin Hematol 2001; 38: 2-4.
36. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol 2001; 38: 14-22.
37. Ware RE, Zimmerman SA, Schultz WH. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999; 94: 3022-6.
38. Helton KJ, Wang WC, Wynn LW et al. The effect of hydroxyurea on vasculopathy in a child with sickle cell disease. Am J Neuroradiol 2002; 23: 1692-6.
39. Vichinsky EP, Lubin BH. A cautionary note regarding hydroxyurea in sickle cell disease. Blood 1994; 83: 1124-8.
40. Walters MC, Sullivan KM, Bernaudin F et al. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 1995; 85: 879-84.
41. Walters MC, Storb R, Patience M et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood 2000; 95: 1918-24.
42. Mentzer WC, Heller S, Pearle PR et al. Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol 1994; 16: 27-9.
43. Steen RG, Helton KJ, Horwitz EM et al. Improved cere-brovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts. Ann Neurol 2001; 49: 222-9.
44. Vermylen C, Cornu G. Bone marrow transplantation for sickle cell disease: the European experience. Am J Pediatr Hematol Oncol 1994; 16: 18-21.
45. Abboud MR, Jackson SM, Barredo J et al. Neurologic complications following bone marrow transplantation for sickle cell disease. Bone Marrow Transplant 1996; 17: 405-7.
46. Kalinyak KA, Morris C, Ball WS et al. Bone marrow transplantation in a young child with sickle cell anemia. Am J Hematol 1995; 48: 256-61.
47. Adams RJ, McKie VC, Carl EM et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997; 42: 699-704.
48. Adams RJ, McKie VC, Brambilla D et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998; 19: 110-29.
49. Anson JA, Koshy M, Ferguson L et al. Subarachnoid hemorrhage in sickle-cell disease [published erratum appears in JNeurosurg 1992; 76: 726]. JNeurosurg 1991; 75: 552-8.
50. McQuaker IG, Jaspan T, McConachie NS et al. Coil embolization of cerebral aneurysms in patients with sickling disorders. Br J Haematol 1999; 106: 388-90.
51. Vernet O, Montes JL, O'Gorman AM et al. Encephalo- duroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease. Pediatr Neurol 1996; 14: 226-30.
52. Pegelow CH, Wang W, Granger S et al. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol, 2001; 58: 2017-21.